Tanaka Eiichi, Chen Frederick Y, Flaumenhaft Robert, Graham Gwenda J, Laurence Rita G, Frangioni John V
Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Mass 02215, USA.
J Thorac Cardiovasc Surg. 2009 Jul;138(1):133-40. doi: 10.1016/j.jtcvs.2008.09.082.
We have developed an image-guided surgical system based on invisible near-infrared fluorescent light. Presently, the only clinically available near-infrared fluorophore is indocyanine green, which fluoresces at approximately 800 nm and is used for coronary angiography. Our objective was to determine whether methylene blue, already US Food and Drug Administration approved for other indications, has useful near-infrared fluorescence properties for image-guided cardiac surgery.
The optical properties of methylene blue were measured after dissolution in 100% serum. Biodistribution and clearance were quantified in organs and tissue after intravenous bolus injection of 2 mg/kg methylene blue in 3 rats. Coronary arteriography and cardiac perfusion were imaged in real time after intravenous bolus injection of 1 mg/kg methylene blue in 5 pigs with coronary obstructions. Coronary angiography and acute thrombi were assessed by using 800-nm fluorophores, indocyanine green, and IR-786-labeled platelets, respectively.
The peak absorbance and emission of methylene blue as a near-infrared fluorophore occur at 667 nm and 686 nm, respectively. After intravenous injection, methylene blue provides highly sensitive coronary angiography. A lipophilic cation, methylene blue is extracted rapidly into tissue, with myocardium displaying unusually high uptake. Methylene blue permits real-time visualization and quantitative assessment of myocardial perfusion. Because of absent spectral overlap, use of 2 independent fluorophores in our imaging system permits simultaneous quantification of perfusion, venous drainage, and/or intravascular thrombi.
Methylene blue is an effective near-infrared fluorophore that provides direct visualization of coronary arteriography and cardiac perfusion. In conjunction with approximately 800-nm near-infrared fluorophores, important functional assessments during cardiac surgery are also possible.
我们开发了一种基于不可见近红外荧光的图像引导手术系统。目前,临床上唯一可用的近红外荧光团是吲哚菁绿,其在约800nm处发出荧光,用于冠状动脉造影。我们的目的是确定已获美国食品药品监督管理局批准用于其他适应症的亚甲蓝是否具有用于图像引导心脏手术的有用近红外荧光特性。
将亚甲蓝溶解在100%血清中后测量其光学特性。对3只大鼠静脉推注2mg/kg亚甲蓝后,对器官和组织中的生物分布和清除情况进行定量。对5只患有冠状动脉阻塞的猪静脉推注1mg/kg亚甲蓝后,实时对冠状动脉造影和心脏灌注进行成像。分别使用800nm荧光团、吲哚菁绿和IR-786标记的血小板评估冠状动脉造影和急性血栓。
亚甲蓝作为近红外荧光团的最大吸收峰和发射峰分别出现在667nm和686nm处。静脉注射后,亚甲蓝可提供高灵敏度的冠状动脉造影。亚甲蓝是一种亲脂性阳离子,可迅速被组织摄取,心肌摄取量异常高。亚甲蓝可实现心肌灌注的实时可视化和定量评估。由于不存在光谱重叠,在我们的成像系统中使用两种独立的荧光团可同时对灌注、静脉引流和/或血管内血栓进行定量。
亚甲蓝是一种有效的近红外荧光团,可直接显示冠状动脉造影和心脏灌注。与约800nm的近红外荧光团联合使用,在心脏手术期间进行重要的功能评估也是可行的。